Disparities in perinatal medicine: preterm birth, stillbirth, and infant mortality

Catherine Y Spong1, Jay Iams, Robert Goldenberg

  • 1From the Pregnancy and Perinatology Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; the Departments of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio, and Drexel University College of Medicine, Philadelphia, Pennsylvania; and Family Medicine and Public Health Sciences, University of Virginia, Charlottesville, Virginia.

Insights

Racial disparities in infant mortality, stillbirths, and preterm births persist in the US. A workshop convened to identify factors contributing to these persistent public health disparities and develop strategies for reduction.

Area of Science:

  • Public Health
  • Maternal and Child Health
  • Health Disparities Research

Background:

  • Infant mortality, stillbirths, and preterm births are critical public health issues.
  • Significant and persistent racial/ethnic disparities exist for these outcomes in the United States.
  • These disparities have remained consistent over the past 30-50 years despite considerable attention.

Purpose of the Study:

  • To summarize findings from a Eunice Kennedy Shriver National Institute of Child Health and Human Development workshop.
  • To identify factors contributing to persistent racial and ethnic disparities in infant mortality, stillbirths, and preterm births.
  • To determine the relative contributions of these factors, identify knowledge gaps, and develop strategies to address these disparities.

Main Methods:

  • The study summarizes a workshop convened by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
  • The workshop focused on analyzing existing data and research regarding racial and ethnic disparities in adverse birth outcomes.
  • Key objectives included identifying contributing factors, assessing their impact, and formulating actionable strategies.

Main Results:

  • Non-Hispanic African Americans experience infant mortality, stillbirth, and preterm birth rates nearly double or significantly higher than the general US population.
  • Infant mortality rate: 13.4 vs. 6.7 per 1,000 live births.
  • Stillbirth rate: 11.1 vs. 6.2 per 1,000 deliveries.
  • Preterm birth rate: 18.4% vs. 12.8% of live births.

Conclusions:

  • Persistent racial and ethnic disparities in infant mortality, stillbirths, and preterm births remain a critical public health challenge.
  • Existing strategies have not effectively reduced these disparities, necessitating new approaches.
  • The workshop aimed to provide a foundation for developing targeted short-term and long-term strategies to mitigate these adverse outcomes.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...